APPENDIX F

Publications


Northeast and Mid-Atlantic Breast Cancer Study (NE/MA)
National Cancer Institute
National Institute of Environmental Health Sciences

Publications

* denotes key publications

(Links to abstracts not provided here may be obtained through the
National Library of Medicines' Pub Med)


Environmental and Genetic Determinants of Breast Cancer
Jo L. Freudenheim, Ph.D.
State University of New York at Buffalo
Buffalo, New York

Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Laughlin R, Nemoto T, Michalek AM, Harrington A, Ford TD, and Shields PG. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 1995;55:3483-3485.

* Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, Harrington AM, Shields PG. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494-1501.

Shields PG, Ambrosone CB, Graham S, Bowman ED, Harrington AM, Gillenwater KA, Marshall JR, Vena JE, Laughlin R, Nemoto T, Freudenheim JL. A cytochrome p4502E1 genetic polymorphism and tobacco smoking in breast cancer. Mol Carcinog 1996;17:144-150.

Ambrosone CB, Freudenheim JL, Sinha R, Graham S, Marshall JR, Vena JE, Laughlin R, Nemoto T, Shields PG. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms. Int J Cancer 1998;75:825-830.

Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status and breast cancer risk. Cancer Res 1998;58:2107-2110.

* Moysich KB, Ambrosone CB, Vena JE, Shields PG, Mendola P, Kostyniak P, Greizerstein H, Graham S, Marshall JR, Schisterman EF, Freudenheim JL. Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:181-188.

Mendola P, Moysich KB, Freudenheim JL, Shields PG, Schisterman EF, Graham S, Vena JE, Marshall JR, Ambrosone CB. Risk of recurrent spontaneous abortion, cigarette smoking, and genetic polymorphisms in NAT2 and GSTM1. Epidemiology 1998;9:666-668.

Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P, Greizerstein H, Marshall JR, Graham S, Ambrosone CB. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:41-44.

Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Shields PG. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999;59:602-606.

Ambrosone CB, Coles BF, Freudenheim JL, Shields PG. Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants. J Nutr 1999;129(Suppl 2):565S-568S.

Moysich KB, Mendola P, Schisterman EF, Freudenheim JL, Arnbrosone CB, Vena JE, Shields PG, Kostyniak P, Greizerstein H, Graham S, Marshall JR. An evaluation of proposed frameworks for grouping polychlorinated biphenyl (PCB) congener data into meaningful analytic units. Am J Ind Med 1999;35:223-231.

* Freudenheim JL, Ambrosone CB, Moysich KB, Vena JE, Graham S, Marshall JR, Muti P, Laughlin R, Nemoto T, Harty LC, Crits GA, Chan AWK, Shields PG. Alcohol dehydrogenase 3 genotype modification of the association of alcohol consumption with breast cancer risk. Cancer Causes Control 1999;10:369-377.

Environmental Factors and Breast Cancer Risk in Maryland
Kathy J. Helzlsouer, M.D.,
Johns Hopkins School of Hygiene and Public Health
Baltimore, Maryland

Lavigne JA, Helzlsouer KJ, Huang H-Y, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, and Yager JD. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 1997;57:5493-5497.

* Helzlsouer KJ, Selmin O, Huang H-Y, Strickland PT, Hoffman S, Alberg AJ, Watson M, Comstock GW, Bell D. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 1998;90:512-518.

Helzlsouer KJ, Huang H-Y, Strickland PT, Hoffman S, Alberg AJ, Comstock GW, Bell DA. Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 1998;7:945-949.

* Wu K, Helzlsouer KJ, Comstock GW, Hoffman SC, Nadeau MR, Selhub J. A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:209-217.

* Helzlsouer KJ, Alberg AJ, Huang H-Y, Hoffman SC, Strickland PT, Brock JW, Burse VW, Needham LL, Bell DA, Lavigne JA, Yager JD, Comstock GW. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:525-532.

Environmental Risk Factors and Breast Cancer in the Nurses' Health Study
David Hunter, M.D., Sc.D.,
Brigham and Women's Hospital
Boston, Massachusetts

Laden F, Wolff MS, Niguidula NJ, Spiegelman D, Hankinson SE, Hunter DJ. Reduced aliquot size for a plasma organochlorine assay for use in epidemiological studies. Cancer Epidemiol Biomarkers Prev 1997;6:333-338.

Kelsey KT, Hankinson SE, Colditz GA, Springer K, Garcia-Closas M, Spiegelman D, Manson JE, Garland M, Stampfer MJ, Willett WC, Speizer FE, Hunter DJ. Glutathione S-transferase class μ deletion polymorphism and breast cancer: results from prevalent versus incident cases. Cancer Epidemiol Biomarkers Prev 1997;6:511-515.

* Laden F, Spiegelman D, Neas LM, Colditz GA, Hankinson SE, Manson JE, Byrne C, Rosner BA, Speizer FE, Hunter DJ. Geographic variation in breast cancer incidence rates in a cohort of U.S. women. J Natl Cancer Inst 1997;89:1373-1378.

* Hunter DJ, Hankinson SE, Laden F, Colditz GA, Manson JE, Willet WC, Speizer FE, Wolff MS. Plasma organochlorine levels and risk of breast cancer. N Engl J Med 1997;337:1253-1258. An editorial accompanies the paper: Safe, SH. Xenoestrogens and breast cancer. N Engl J Med 1997;337:1303-1304 (journal abstract not available on the Web). Correspondence is published: vom Saal FS, Welshons WV, Hansen LG. Organochlorine residues and breast cancer. N Engl J Med 1998;338:988; and, Talbott EO, Zborowski JV, Kuller LH. Organochlorine residues and breast cancer. N Engl J Med 1998;338:988-989; discussion 991 (journal correspondence not available on the Web).

Hunter DJ, Hankinson SE, Hough H, Gertig DM, Garcia-Closas M, Spiegelman D, Manson JE, Colditz GA, Willett WC, Speizer FE, Kelsey K. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis 1997;18:2127-2132.

Ishibe N, Hankinson SE, Colditz GA, Spiegelman D, Willett WC, Speizer FE, Kelsey KT, Hunter DJ. Cigarette smoking, cytochrome P450 1Al polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res 1998;58:667-671.

Laden F, Hunter DJ. Environmental risk factors and female breast cancer. Annu Rev Public Health 1998;19:101-123.

* Laden F, Neas LM, Spiegelman D, Hankinson SE, Willett WC, Ireland K, Wolff MS, Hunter DJ. Predictors of plasma concentrations of DDE and PCBs in a group of U.S. women. Environ Health Perspect 1999;107:75-81.

Laden F, Neas LM, Tolbert PE, Holmes MD, Hankinson SE, Spiegelman D, Speizer FE, Hunter DJ. Electric blanket use and breast cancer in the Nurses' Health Study. Am J Epidemiol 2000;152:41-49.

EMF and Breast Cancer on Long Island
Cristina M. Leske, M.D.
State University of New York at Stony Brook
Stony Brook, New York

* Schoenfeld ER, Henderson K, O'Leary E, Grimson R, Kaune W, Leske MC. Magnetic field exposure assessment: A comparison of various methods. Bioelectromagnetics 1999;20:487-496.

Caplan LS, Schoenfeld ER, O'Leary ES, Leske MC. Breast cancer and electromagnetic fields - a review. Ann Epidemiol 2000;10:31-44.

Environmental and Genetic Determinants of Breast Cancer
Mary Wolff, Ph.D.
Mount Sinai School of Medicine
New York, New York

Wolff MS, Camann D, Gammon M, Stellman SD. Proposed PCB congener groupings for epidemiological studies. Environ Health Perspect 1997;105:13-14 (Letter).

* Weston A, Pan C, Ksieski HB, Wallenstein S, Berkowitz GS, Tartter PI, Bleiweiss IJ, Brower ST, Senie RT, Wolff MS. p53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev 1997;6:105-112.

* Weston A, Pan CF, Bleiweiss IJ, Ksieski HB, Roy N, Maloney N, Wolff MS. CYP17 genotype and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:941-944.

Weston A, Wolff MS, Morabia A. True extended haplotypes of p53: indicators of breast cancer risk. Cancer Genet Cytogenet 1998;102:153-154.

Wolff MS, Zeleniuch-Jacquotte A, Dubin N, Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 2000;9:271-277.

Wolff MS, Berkowitz GS, Brower S, Senie R, Bleiweiss IJ, Tartter PI, Pace B, Roy N, Wallenstein S, Weston A. Organochlorine exposures and breast cancer risk in New York City women. Environ Res (in press).

Organochlorine Compounds and Risk of Breast Cancer
Tongzhang Zheng, M.D., Sc.D.
Yale University School of Medicine
New Haven, Connecticut

Archibeque-Engle S, Tessari JD, Winn DT. Quality assurance/quality control procedures for chlorinated hydrocarbons in human breast adipose tissue. J Toxicol Environ Health 1996;49:589-598.

Archibeque-Engle SL, Tessari JD, Winn DT, Keefe TJ, Nett TM, Zheng T. Comparison of organochlorine pesticide and polychlorinated biphenyl residues in human breast adipose tissue and serum. J Toxicol Environ Health 1997;52:285-293.

Tessari JD, Archibeque-Engle SL. Cancer Epidemiol Biomarkers Prev 1999;8:111-114. Correspondence re: SD Stellman et al., Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer Epidemiol Biomarkers Prev 1998;7:489-496.

* Zheng T, Holford TR, Mayne ST, Owens PH, Ward B, Carter D, Dubrow R, Zahm SH, Boyle P, Tessari J. Beta-benzene hexachloride in breast adipose tissue and risk of breast carcinoma. Cancer 1999;85:2212-2218.

* Zheng T, Holford TR, Mayne ST, Tessari J, Owens PH, Zahm SH, Zhang B, Dubrow R, Ward B, Carter D, Boyle P. Environmental exposure to hexachlorobenzene (HCB) and risk of female breast cancer in Connecticut. Cancer Epidemiol Biomarkers Prev 1999;8:407-411.

* Zheng T, Holford TR, Mayne ST, Ward B, Carter D, Owens PH, Dubrow R, Zahm SH, Boyle P, Archibeque-Engle S, Tessari J. DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol 1999;150:453-458.

Zheng T, Holford TR, Tessari J, Mayne ST, Owens PH, Ward B, Carter D, Boyle P, Dubrow R, Archibeque-Engle S, Zahm SH. Breast cancer risk associated with congeners of polychlorinated biphenyls. Am J Epidemiol 2000;152:50-58.

Zheng T, Holford TR, Mayne ST, Owens PH, Zhang B, Boyle P, Carter D, Ward B, Zhang Y, Zahm SH. Exposure to electromagnetic fields from use of electric blankets and other in-home electrical appliances and breast cancer risk. Am J Epidemio l 2000;151:1103-1011.

Zheng T, Holford TR, Mayne ST, Tessari J, Ward B, Carter D, Owens PH, Boyle P, Dubrow R, Archibeque-Engle S, Dawood O, Zahm SH. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev 2000;9:167-174.

Zheng T, Holford TR, Tessari J, Mayne ST, Zahm SH, Owens PH, Zhang B, Ward B, Carter D, Zhang Y, Zhang W, Dubrow R, Boyle P. Oxychlordane and tran-nonachlor in breast adipose tissue and risk of female breast cancer. J Epidemiol Statistics (in press).

Holford TR, Zheng T, Mayne ST, Zahm SH, Tessari J, Boyle P. Joint effects of nine PCB cogeners on breast cancer risk. Int J Epidemiol (in press).